Home › Therapeutic areas › Cardiovascular › Pulmonary Hypertension Associated with Interstitial Lung Disease
Pulmonary Hypertension Associated with Interstitial Lung Disease (4 companies)
Companies with an active program in Pulmonary Hypertension Associated with Interstitial Lung Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio | Cardiovascular Rare | 2 | NDA Submitted | — | 4 |
| INSM | Insmed | CardiovascularImmunology+3 Rare | 1 | Approved | $25.1B | 15 |
| LQDA | Liquidia | CardiovascularImmunology+1 Rare | 1 | Approved | $3.97B | 9 |
| TECX | Tectonic Therapeutic | Cardiovascular Rare | 1 | Phase 2 | $412M | 4 |
No companies match.